Contact Us

We are always interested in new business opportunities. Contact us using the form the right and we will get back to you shortly.

Full Name *
Full Name

10 E.Ontario St. #3303
Chicago, IL 60611
USA

312-288-1350

Dr. Stephen A. Di Biase served as the Chief Executive Officer of Laser Applications Technology (LAT) LLC and as currently President of Premier Insights, LLC. He is an entrepreneur, building businesses and capabilities from emerging technology.  In leading LAT, Dr. Di Biase developed the business model and go to market strategies for introducing a disruptive technology for labeling produce.  With Premier Insights, Dr. Di Biase teaches leaders how to become more innovative by making innovation a discipline they can refine.

During his 40 year career, Dr. Di Biase has become accomplished in using innovation to create value in a global commercial setting.  He has over 20 patents, mentored technical professionals, and taught innovation and human resource management in both corporate and university settings. He has guest lectured at several academic institutions and has authored books, patents and corporate publications. 

Dr. Di Biase graduated from The Pennsylvania State University and sits on the Science Advisory Board for The Pennsylvania State University. He is also a retired member of the Board of Trustees for the Mt. Union College, and has served on the Board of Directors of the Industrial Research Institute, a leading experienced based innovation management association.

Prior to joining JohnsonDiversey, Dr. Di Biase spent 26 years with the Lubrizol Corporation, where he held a variety of leadership positions, including general management roles and those with profit and loss responsibility for emerging businesses derived from technology platforms.  These global assignments often involved business development from strategy conception to execution managing teams of Sales, Marketing, and Business Development professionals.

Prior to accepting the assignment in business development Dr. Di Biase was the Vice President – Research, Development, and Engineering where he was responsible for the global technical and scientific leadership for a centralized R&D function comprising of 700 professionals, an operating budget of $120+ million, and a capital budget of $10+ million. 

In this role Dr. Di Biase fostered innovation and delivered results using processes such as stage gates, project and portfolio management, 6-Sigma, and advanced statistics while introducing a variety of IT based tools such as data mining and predictive modeling.

Dr. Di Biase has served as chairman of The Lubrizol Foundation Scholarship Committee, Chairman of the Northeastern Ohio Section of the American Chemical Society, Board member of the Cleveland Area Research Directors (CARD) and in The Boy Scouts of America where he served in a variety of posts.   Dr. Di Biase has been honored by The Pennsylvania State University College of Science with its 2007 Distinguished Alumni Award and serves as an adjunct professor at Benedictine University in Naperville IL.

 

 

 

 

 

Food for Thought

Odor Mitigation Case Study

Stephen Di Biase

Case Study – Odor Mitigation by The Platform

The Platform is a business development opportunity enabled by a technology platform based on a trade secret formulation of enzymes, penetrants and surfactants capable of activating natural agents in a system to do work. Specifically The Platform acts as a catalyst to help natural materials, such as bacteria, destroy pollutants.  This work can be digesting waste, cleaning surfaces, managing biofilms etc.

It’s well recognized that natural systems are often the most cost effective in creating outcomes and often mimicked by human activities.  Perhaps the most obvious example is treating human illnesses with antibiotics by copying natural processes and materials in the laboratory.  The simple conclusion is that finding ways to help nature do what it does best can be very commercially attractive.

The Platform appears from field observations and published reports, to be able to facilitate natural processes to function more effectively. In essence, The Platform is behaving like a catalyst, meaning it can be employed at very low treatment levels, suggesting attractive economics.

A critical observation is that The Platform activity has been reported from fermented products indicating our observations are substantiated. However, fermented products are very limited in their applications since they must be prepared by biological processes.  The Platform is a formulated product from readily available, low-risk materials, making it potentially very board in its applicability and not limited as other competitive naturally derived offerings.

The Platform has proven to be commercial effective of  in 5 unique applications suggesting the basic mechanism of “catalytic system activation” is occurring. Successful commercialization has occurred in Municipal Waste Water Treatment (MWWT), lagoon treatment, cooling tower management, deodorization of air scrubber systems, and waste control of Concentrated Animal Farm Operations (CAFOs).  These field observations are supported indirectly by laboratory results involving synergistic effects with known biocide compounds and microbial metabolism studies.

In every application, the value proposition has been compelling resulting in nearly universal acceptance of The Platform program at EBITDA returns in excess of 20%. Further, there have been no customer losses once The Platform program has been adopted.

The U. S. market potential of the aforementioned applications is $3-5 billion USD of which we believe ~$100 MM is accessible within a 3-5 year timeframe.  In addition, geographic expansion and yet to be studied applications, such as biocide additives, CAFOs and aquaculture offer significant upside growth opportunity.